Profitability often eludes small companies seeking to expand their businesses, and for home dialysis specialist NxStage Medical , the challenge of spending money on research and development while also ...
NxStage Medical (NASDAQ: NXTM) has been in limbo since mid-2017, when it received an offer from Fresenius Medical Care (NYSE: FMS) to buy the company. Since then, shares of NxStage have stayed ...
NxStage is consistently outperforming the market. Revenues and sales are steadily rising. The company has growth potential in new developments and expansions. NxStage Medical, Inc. (NXTM), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results